Kimberly M. Deininger

MedicinePharmacology, Toxicology and PharmaceuticsImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients”.

Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients

The Pharmacogenomics Journal(2024)10.1038/s41397-024-00325-2

N/A

0.396DataRank · unranked

13 citations

S Garcia Hernandez, Christina L. Aquilante, Kimberly M. Deininger, JoAnn Lindenfeld, Kelly Schlendorf +2 more

Association Between Variants in Calcineurin Inhibitor Pharmacokinetic and Pharmacodynamic Genes and Renal Dysfunction in Adult Heart Transplant Recipients

Frontiers in Genetics(2021)10.3389/fgene.2021.658983

N/A

0.269DataRank · unranked

5 citations

Laura Saba, Nicholas Rafaels, Amrut V. Ambardekar, Kimberly M. Deininger, Robert L. Page +3 more

Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients

The Journal of Heart and Lung Transplantation(2021)10.1016/j.healun.2021.05.020

N/A

0DataRank · unranked

15 citations

Laura Saba, Nicholas Rafaels, Amrut V. Ambardekar, Kimberly M. Deininger, RobertL. PageII +3 more